Mode
Text Size
Log in / Sign up

Hybrid deep learning and large language model framework achieves 0.97 accuracy in MACE risk predictionAI Tool Predicts Heart Risk with 97% Accuracy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that the hybrid AI model achieves 0.97 prediction accuracy but requires clinician oversight for OTC medication safety.

This technology validation study evaluates a hybrid framework combining a 1D-CNN for MACE risk prediction with a RAG pipeline using MISTRAL AI to provide clinical recommendations. The system aims to support decision-making and personalized cardiovascular management through automated risk assessment and evidence-based guidance.

The model demonstrated high performance metrics, including a 0.97 prediction accuracy, 1.00 precision and recall for the MACE class, and a 0.98 F1-score. Furthermore, the system achieved 5/5 scores for both WHO and AHA guideline fidelity as well as dietary and lifestyle guidance. Clinical safety was rated at 4/5.

A notable limitation identified by the authors is that OTC medication caution was only moderate at 3/5. The framework is intended as a clinical decision support tool rather than a replacement for professional judgment. While it provides high accuracy in risk prediction, its specific limitations regarding over-the-counter medications suggest a need for careful clinician oversight when interpreting automated recommendations.

Researchers have developed a new AI system that predicts the risk of major cardiovascular events, such as heart attacks and strokes, with 97% accuracy. The system uses a type of artificial intelligence called a 1D-CNN to analyze patient data and a large language model to provide personalized recommendations. This technology was tested using electronic medical records from patients at a hospital in South Korea.

The AI system was very good at identifying patients at high risk, with perfect precision and recall for the highest risk group, and an F1-score of 0.98. It also performed well in providing recommendations that follow guidelines from the World Health Organization and the American Heart Association, scoring 5 out of 5 for guideline fidelity. It also scored 5 out of 5 for dietary and lifestyle guidance, and 4 out of 5 for clinical safety.

However, the system only scored 3 out of 5 for caution about over-the-counter (OTC) medications, meaning it might not always warn about potential risks. The study is a technical validation, not a clinical trial, so it's not yet clear how well it works in real-world settings. The researchers note that the AI is a decision-support tool, not a replacement for a doctor's judgment.

For now, this AI system shows promise in helping doctors predict cardiovascular risk and offer personalized advice. But more research is needed to confirm its benefits and to improve its safety recommendations. Patients should continue to rely on their healthcare providers for medical advice.

What this means for you:
AI shows promise in predicting heart risk and offering guidance, but it's not ready to replace doctors.

Common questions

How accurate is this AI at predicting heart risk?

The AI system predicted major cardiovascular events with 97% accuracy. It also had perfect precision and recall for the highest risk group, and an F1-score of 0.98, meaning it was very good at identifying those at risk.

Does this AI give safe recommendations?

The AI scored 4 out of 5 for clinical safety and 5 out of 5 for following guidelines from WHO and AHA. However, it only scored 3 out of 5 for caution about over-the-counter medications, so it might not always warn about potential risks.

Can this AI replace my doctor?

No. This AI is a decision-support tool, not a replacement for clinical judgment. It is designed to help doctors make better decisions, but you should always consult your healthcare provider for medical advice.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedAug 2026
View Original Abstract ↓
BackgroundMajor adverse cardiovascular events (MACE) remain a leading cause of global morbidity and mortality, necessitating accurate risk prediction and actionable prevention strategies. This study proposes a two-fold framework integrating deep learning and large language models (LLMs) to predict MACE risk and generate personalized, guideline-based recommendations.MethodsEmergency medical record (EMR) data from Chungbuk National University (CBNU) Hospital were preprocessed and split into training and test sets, with class imbalance addressed using SMOTETomek. A one-dimensional convolutional neural network (1D-CNN) was developed to predict individual MACE risk from clinical features. To translate predictions into practice, a retrieval-augmented generation (RAG) pipeline with prompt engineering was implemented using LLM Model (MISTRAL AI), grounded in WHO and AHA cardiovascular prevention guidelines. Predictive performance was evaluated using accuracy, precision, recall, and F1-score. The recommendation system was assessed using a rubric-based LLM judge evaluating guideline fidelity, clinical safety, dietary plans, lifestyle/exercise guidance, and OTC medication caution.ResultsThe proposed1D-CNN achieved strong performance, with overall accuracy of 0.97. For the MACE class, precision and recall reached 1.00, with an F1-score of 0.98. The recommendation system demonstrated high guideline fidelity (5/5 for both WHO and AHA), strong dietary and lifestyle guidance (5/5), good clinical safety (4/5), and moderate OTC medication caution (3/5).ConclusionThe proposed framework effectively combines accurate MACE risk prediction with interpretable, evidence-based preventive recommendations delivered via a web interface. This integrated approach supports clinical decision-making and personalized cardiovascular risk management.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.